{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:55:53Z","timestamp":1771455353843,"version":"3.50.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,19]]},"DOI":"10.7759\/cureus.80843","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:40:16Z","timestamp":1742409616000},"source":"Crossref","is-referenced-by-count":3,"title":["Exploring the Impact of Diabetes on Kidney Transplant: Patient Outcomes and Management Strategies"],"prefix":"10.7759","author":[{"given":"Hiba Hatim H","family":"Eltayeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Felipe","family":"Salazar Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah N","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime T","family":"Lee Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Algitagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lintha Z","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikhlas U","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhya","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zummar F","family":"Asad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqrah A","family":"Issimdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humza F","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/diabetology2020004","article-title":"Diabetes mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management","volume":"2","author":"Alam S","year":"2021","unstructured":"Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. 2021, 2:36-50. 10.3390\/diabetology2020004","journal-title":"Diabetology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0506-9","article-title":"Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft","volume":"20","author":"Hau HM","year":"2020","unstructured":"Hau HM, Jahn N, Brunotte M, et al.. Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft. BMC Endocr Disord. 2020, 20:30. 10.1186\/s12902-020-0506-9","journal-title":"BMC Endocr Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22 Suppl 1","author":"Selby NM","year":"2020","unstructured":"Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020, 22 Suppl 1:3-15. 10.1111\/dom.14007","journal-title":"Diabetes Obes Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13860","article-title":"Update on diagnosis, pathophysiology, and management of diabetic kidney disease","volume":"26","author":"Sugahara M","year":"2021","unstructured":"Sugahara M, Pak WL, Tanaka T, Tang SC, Nangaku M. Update on diagnosis, pathophysiology, and management of diabetic kidney disease. Nephrology (Carlton). 2021, 26:491-500. 10.1111\/nep.13860","journal-title":"Nephrology (Carlton)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810222","article-title":"Novel insights into diabetic kidney disease","volume":"25","author":"M\u0142ynarska E","year":"2024","unstructured":"M\u0142ynarska E, Bu\u0142awska D, Czarnik W, et al.. Novel insights into diabetic kidney disease. Int J Mol Sci. 2024, 25:10222. 10.3390\/ijms251810222","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111453","article-title":"The pathogenesis of end-stage renal disease from the standpoint of the theory of general pathological processes of inflammation","volume":"22","author":"Gusev E","year":"2021","unstructured":"Gusev E, Solomatina L, Zhuravleva Y, Sarapultsev A. The pathogenesis of end-stage renal disease from the standpoint of the theory of general pathological processes of inflammation. Int J Mol Sci. 2021, 22:11453. 10.3390\/ijms222111453","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1264497","article-title":"Treatment and practical considerations of diabetic kidney disease","volume":"10","author":"Bilen Y","year":"2023","unstructured":"Bilen Y, Almoushref A, Alkwatli K, Osman O, Mehdi A, Sawaf H. Treatment and practical considerations of diabetic kidney disease. Front Med (Lausanne). 2023, 10:1264497. 10.3389\/fmed.2023.1264497","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007374.pub3","article-title":"Education programmes for people with chronic kidney disease and diabetes","volume":"8","author":"Cashmore BA","year":"2024","unstructured":"Cashmore BA, Cooper TE, Evangelidis NM, Green SC, Lopez-Vargas P, Tunnicliffe DJ. Education programmes for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2024, 8:CD007374. 10.1002\/14651858.CD007374.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4061269","article-title":"Kidney transplantation in the diabetic patient","volume":"4","author":"P\u00e9rez-S\u00e1ez MJ","year":"2015","unstructured":"P\u00e9rez-S\u00e1ez MJ, Pascual J. Kidney transplantation in the diabetic patient. J Clin Med. 2015, 4:1269-80. 10.3390\/jcm4061269","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144602","article-title":"Final stage of chronic kidney disease with conservative kidney management or renal replacement therapy: a primary-care population study","volume":"12","author":"Bund\u00f3 D","year":"2023","unstructured":"Bund\u00f3 D, Cunillera O, Arbiol-Roca A, et al.. Final stage of chronic kidney disease with conservative kidney management or renal replacement therapy: a primary-care population study. J Clin Med. 2023, 12:4602. 10.3390\/jcm12144602","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132943","article-title":"Management of kidney failure in patients with diabetes mellitus: what are the best options?","volume":"10","author":"Buades JM","year":"2021","unstructured":"Buades JM, Craver L, Del Pino MD, et al.. Management of kidney failure in patients with diabetes mellitus: what are the best options?. J Clin Med. 2021, 10:2943. 10.3390\/jcm10132943","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2022.08.024","article-title":"Outcome of renal transplantation in patients with diabetes mellitus: a single-center experience","volume":"54","author":"Akagun T","year":"2022","unstructured":"Akagun T, Yelken B, Usta M, Turkmen A. Outcome of renal transplantation in patients with diabetes mellitus: a single-center experience. Transplant Proc. 2022, 54:2174-8. 10.1016\/j.transproceed.2022.08.024","journal-title":"Transplant Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2021.02.010","article-title":"Epidemiology of end-stage kidney disease","volume":"34","author":"Gupta R","year":"2021","unstructured":"Gupta R, Woo K, Yi JA. Epidemiology of end-stage kidney disease. Semin Vasc Surg. 2021, 34:71-8. 10.1053\/j.semvascsurg.2021.02.010","journal-title":"Semin Vasc Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i5.541","article-title":"Recent advances in new-onset diabetes mellitus after kidney transplantation","volume":"12","author":"Montada-Atin T","year":"2021","unstructured":"Montada-Atin T, Prasad GV. Recent advances in new-onset diabetes mellitus after kidney transplantation. World J Diabetes. 2021, 12:541-55. 10.4239\/wjd.v12.i5.541","journal-title":"World J Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00141","article-title":"Diabetes mellitus in the transplanted kidney","volume":"5","author":"Peev V","year":"2014","unstructured":"Peev V, Reiser J, Alachkar N. Diabetes mellitus in the transplanted kidney. Front Endocrinol (Lausanne). 2014, 5:141. 10.3389\/fendo.2014.00141","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071928","article-title":"New-onset diabetes mellitus after kidney transplantation","volume":"13","author":"Alajous S","year":"2024","unstructured":"Alajous S, Budhiraja P. New-onset diabetes mellitus after kidney transplantation. J Clin Med. 2024, 13:1928. 10.3390\/jcm13071928","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.11.018","article-title":"Diabetes control and the risks of ESRD and mortality in\u00a0patients\u00a0with CKD","volume":"70","author":"Navaneethan SD","year":"2017","unstructured":"Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr. Diabetes control and the risks of ESRD and mortality in\u00a0patients\u00a0with CKD. Am J Kidney Dis. 2017, 70:191-8. 10.1053\/j.ajkd.2016.11.018","journal-title":"Am J Kidney Dis"},{"key":"ref18","article-title":"Simultaneous pancreas-kidney transplantation: an overview of indications, complications, and outcomes","volume":"170","author":"Freise CE","year":"1999","unstructured":"Freise CE, Narumi S, Stock PG, Melzer JS. Simultaneous pancreas-kidney transplantation: an overview of indications, complications, and outcomes. West J Med. 1999, 170:11-8.","journal-title":"West J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.12235","article-title":"Infection-related hospitalizations after simultaneous pancreas-kidney transplantation compared to kidney transplantation alone","volume":"37","author":"Grasberger J","year":"2024","unstructured":"Grasberger J, Ortiz F, Ekstrand A, et al.. Infection-related hospitalizations after simultaneous pancreas-kidney transplantation compared to kidney transplantation alone. Transpl Int. 2024, 37:12235. 10.3389\/ti.2024.12235","journal-title":"Transpl Int"},{"key":"ref20","article-title":"Acute graft thrombosis in patients who underwent renal transplant and received anticoagulant or antiplatelet agents. A systematic review and meta-analysis","volume":"10","author":"Guerra R","year":"2022","unstructured":"Guerra R, Kawano PR, Amaro MP, et al.. Acute graft thrombosis in patients who underwent renal transplant and received anticoagulant or antiplatelet agents. A systematic review and meta-analysis. Am J Clin Exp Urol. 2022, 10:129-41.","journal-title":"Am J Clin Exp Urol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2016.05.017","article-title":"Human immunodeficiency virus in kidney transplantation","volume":"36","author":"Degnan KO","year":"2016","unstructured":"Degnan KO, Blumberg EA. Human immunodeficiency virus in kidney transplantation. Semin Nephrol. 2016, 36:405-16. 10.1016\/j.semnephrol.2016.05.017","journal-title":"Semin Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041193","article-title":"Recent advances and clinical outcomes of kidney transplantation","volume":"9","author":"Thongprayoon C","year":"2020","unstructured":"Thongprayoon C, Hansrivijit P, Leeaphorn N, et al.. Recent advances and clinical outcomes of kidney transplantation. J Clin Med. 2020, 9:1193. 10.3390\/jcm9041193","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.85gr.18001","article-title":"Kidney transplant: new opportunities and challenges","volume":"85","author":"Augustine J","year":"2018","unstructured":"Augustine J. Kidney transplant: new opportunities and challenges. Cleve Clin J Med. 2018, 85:138-44. 10.3949\/ccjm.85gr.18001","journal-title":"Cleve Clin J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy151","article-title":"Metabolic risk profile in kidney transplant candidates and recipients","volume":"34","author":"Piotti G","year":"2019","unstructured":"Piotti G, Gandolfini I, Palmisano A, Maggiore U. Metabolic risk profile in kidney transplant candidates and recipients. Nephrol Dial Transplant. 2019, 34:388-400. 10.1093\/ndt\/gfy151","journal-title":"Nephrol Dial Transplant"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10064","article-title":"Kidney and liver transplantation in the elderly","volume":"103","author":"Sutherland AI","year":"2016","unstructured":"Sutherland AI, IJzermans JN, Forsythe JL, Dor FJ. Kidney and liver transplantation in the elderly. Br J Surg. 2016, 103:e62-72. 10.1002\/bjs.10064","journal-title":"Br J Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05030-x","article-title":"Medical contraindications to transplant listing in the USA: a survey of adult and pediatric heart, kidney, liver, and lung programs","volume":"43","author":"Wall A","year":"2019","unstructured":"Wall A, Lee GH, Maldonado J, Magnus D. Medical contraindications to transplant listing in the USA: a survey of adult and pediatric heart, kidney, liver, and lung programs. World J Surg. 2019, 43:2300-8. 10.1007\/s00268-019-05030-x","journal-title":"World J Surg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2023.1236520","article-title":"Blood transfusions post kidney transplantation are associated with inferior allograft and patient survival-it is time for rigorous patient blood management","volume":"3","author":"Hassan S","year":"2023","unstructured":"Hassan S, Mumford L, Robinson S, et al.. Blood transfusions post kidney transplantation are associated with inferior allograft and patient survival-it is time for rigorous patient blood management. Front Nephrol. 2023, 3:1236520. 10.3389\/fneph.2023.1236520","journal-title":"Front Nephrol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2015.11.003","article-title":"Surgical complications after simultaneous pancreas-kidney transplantation: a single-center experience","volume":"39","author":"Khubutia MS","year":"2016","unstructured":"Khubutia MS, Pinchuk AV, Dmitriev IV, Balkarov AG, Storozhev RV, Anisimov YA. Surgical complications after simultaneous pancreas-kidney transplantation: a single-center experience. Asian J Surg. 2016, 39:232-7. 10.1016\/j.asjsur.2015.11.003","journal-title":"Asian J Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v13.i5.208","article-title":"Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: current perspectives","volume":"13","author":"Nagendra L","year":"2023","unstructured":"Nagendra L, Fernandez CJ, Pappachan JM. Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: current perspectives. World J Transplant. 2023, 13:208-20. 10.5500\/wjt.v13.i5.208","journal-title":"World J Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13392","article-title":"Influence of surgical complications on outcomes in kidney transplantation patients","volume":"37","author":"Lai GS","year":"2023","unstructured":"Lai GS, Li JR, Wang SS, et al.. Influence of surgical complications on outcomes in kidney transplantation patients. In Vivo. 2023, 37:2796-802. 10.21873\/invivo.13392","journal-title":"In Vivo"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjane.2024.844556","article-title":"Kidney transplantation and perioperative complications: a prospective cohort study","volume":"74","author":"Dal Magro PS","year":"2024","unstructured":"Dal Magro PS, Meinerz G, Garcia VD, Mendes FF, Marques ME, Keitel E. Kidney transplantation and perioperative complications: a prospective cohort study. Braz J Anesthesiol. 2024, 74:844556. 10.1016\/j.bjane.2024.844556","journal-title":"Braz J Anesthesiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.6002\/ect.MESOT2023.P74","article-title":"Long-term kidney transplant graft survival: single-center experience","volume":"22","author":"Ismayilov H","year":"2024","unstructured":"Ismayilov H, Hasanova Z, Huseynov K, Babayev F. Long-term kidney transplant graft survival: single-center experience. Exp Clin Transplant. 2024, 22:263-4. 10.6002\/ect.MESOT2023.P74","journal-title":"Exp Clin Transplant"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14506","article-title":"Abdominal wall complications after kidney transplantation: a clinical review","volume":"35","author":"Gioco R","year":"2021","unstructured":"Gioco R, Sanfilippo C, Veroux P, et al.. Abdominal wall complications after kidney transplantation: a clinical review. Clin Transplant. 2021, 35:e14506. 10.1111\/ctr.14506","journal-title":"Clin Transplant"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3575","article-title":"Acute diabetic foot in post kidney transplantation patients receiving chronic immunosuppression-clinical presentation and outcomes","volume":"38","author":"Gorin K","year":"2022","unstructured":"Gorin K, Cahn A, Leibovitch M, et al.. Acute diabetic foot in post kidney transplantation patients receiving chronic immunosuppression-clinical presentation and outcomes. Diabetes Metab Res Rev. 2022, 38:e3575. 10.1002\/dmrr.3575","journal-title":"Diabetes Metab Res Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.7635","article-title":"Simultaneous pancreas-kidney transplantation: early complications and long-term outcomes - a single-center experience","volume":"16","author":"Vidal Crespo N","year":"2022","unstructured":"Vidal Crespo N, L\u00f3pez Cubillana P, L\u00f3pez Gonz\u00e1lez PA, et al.. Simultaneous pancreas-kidney transplantation: early complications and long-term outcomes - a single-center experience. Can Urol Assoc J. 2022, 16:E357-62. 10.5489\/cuaj.7635","journal-title":"Can Urol Assoc J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101488","article-title":"Diabetes mellitus as a predictive factor for urinary tract infection for patients treated with kidney transplantation","volume":"58","author":"Ozawa K","year":"2022","unstructured":"Ozawa K, Takai M, Taniguchi T, et al.. Diabetes mellitus as a predictive factor for urinary tract infection for patients treated with kidney transplantation. Medicina (Kaunas). 2022, 58:1488. 10.3390\/medicina58101488","journal-title":"Medicina (Kaunas)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5114\/ko.2023.126356","article-title":"Ophthalmic evaluation in patients after simultaneous pancreas-kidney transplantation (SPK) due to complications of type 1 diabetes mellitus, and in type 1 diabetic patients assessed for eligibility for SPK","volume":"125","author":"Shein A","year":"2023","unstructured":"Shein A, Durlik M, Malukiewicz G. Ophthalmic evaluation in patients after simultaneous pancreas-kidney transplantation (SPK) due to complications of type 1 diabetes mellitus, and in type 1 diabetic patients assessed for eligibility for SPK. Klin Oczna. 2023, 125:17-26. 10.5114\/ko.2023.126356","journal-title":"Klin Oczna"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/15347346211052155","article-title":"Incidence and risk factors of diabetic foot syndrome in patients early after pancreas or kidney\/pancreas transplantation and its association with preventive measures","volume":"23","author":"Vr\u00e1tn\u00e1 E","year":"2024","unstructured":"Vr\u00e1tn\u00e1 E, Hus\u00e1kov\u00e1 J, Kr\u00e1lov\u00e1 K, et al.. Incidence and risk factors of diabetic foot syndrome in patients early after pancreas or kidney\/pancreas transplantation and its association with preventive measures. Int J Low Extrem Wounds. 2024, 23:283-90. 10.1177\/15347346211052155","journal-title":"Int J Low Extrem Wounds"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad738","article-title":"Evaluation of microvascular complications in kidney recipients with posttransplant diabetes mellitus","volume":"109","author":"\u00c7elik Kavakl\u0131lar B","year":"2024","unstructured":"\u00c7elik Kavakl\u0131lar B, Ayb\u0131 \u00d6zdemir \u00d6, Y\u0131ld\u0131r\u0131m T, et al.. Evaluation of microvascular complications in kidney recipients with posttransplant diabetes mellitus. J Clin Endocrinol Metab. 2024, 109:e1623-33. 10.1210\/clinem\/dgad738","journal-title":"J Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v50i8.6801","article-title":"Graft and patient survival rates in kidney transplantation, and their associated factors: a systematic review and meta-analysis","volume":"50","author":"Ghelichi-Ghojogh M","year":"2021","unstructured":"Ghelichi-Ghojogh M, Ghaem H, Mohammadizadeh F, et al.. Graft and patient survival rates in kidney transplantation, and their associated factors: a systematic review and meta-analysis. Iran J Public Health. 2021, 50:1555-63. 10.18502\/ijph.v50i8.6801","journal-title":"Iran J Public Health"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13087","article-title":"Analysis of rejection, infection and surgical outcomes in type I versus type II diabetic recipients after simultaneous pancreas-kidney transplantation","volume":"37","author":"Martinez EJ","year":"2024","unstructured":"Martinez EJ, Pham PH, Wang JF, et al.. Analysis of rejection, infection and surgical outcomes in type I versus type II diabetic recipients after simultaneous pancreas-kidney transplantation. Transpl Int. 2024, 37:13087. 10.3389\/ti.2024.13087","journal-title":"Transpl Int"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich M","year":"2019","unstructured":"Oellerich M, Shipkova M, Asendorf T, et al.. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study. Am J Transplant. 2019, 19:3087-99. 10.1111\/ajt.15416","journal-title":"Am J Transplant"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.17352\/acn.000057","article-title":"Impact of diabetes mellitus on renal transplant outcome","volume":"7","author":"Muhammad Tanzeel A","year":"2021","unstructured":"Muhammad Tanzeel A, Mariam A, Nayyar S. Impact of diabetes mellitus on renal transplant outcome. Arch Clin Nephrol. 2021, 7:57-64. 10.17352\/acn.000057","journal-title":"Arch Clin Nephrol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2022.41.305.31067","article-title":"Readmissions to kidney transplantation department: incidence, causes and risk factors","volume":"41","author":"Tlili S","year":"2022","unstructured":"Tlili S, Fatma LB, Mami I, et al.. Readmissions to kidney transplantation department: incidence, causes and risk factors. Pan Afr Med J. 2022, 41:305. 10.11604\/pamj.2022.41.305.31067","journal-title":"Pan Afr Med J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001962","article-title":"Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA","volume":"9","author":"Harding JL","year":"2021","unstructured":"Harding JL, Pavkov M, Wang Z, et al.. Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA. BMJ Open Diabetes Res Care. 2021, 9:10.1136\/bmjdrc-2020-001962","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02101.x","article-title":"Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes","volume":"8","author":"Cosio FG","year":"2008","unstructured":"Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008, 8:593-9. 10.1111\/j.1600-6143.2007.02101.x","journal-title":"Am J Transplant"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.15761\/TiT.1000287","article-title":"Kidney graft survival at a year, clinical evolution and associated factors in transplant patients with pre-existing diabetes","volume":"14","author":"Rojas-Arzola LJ","year":"2020","unstructured":"Rojas-Arzola LJ, Espinoza-P\u00e9rez R, Cruz-L\u00f3pez M, Hern\u00e1ndez-Rivera JC, Paniagua-Sierra R. Kidney graft survival at a year, clinical evolution and associated factors in transplant patients with pre-existing diabetes. Trends Transpl. 2020, 14:287. 10.15761\/TiT.1000287","journal-title":"Trends Transpl"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg338","article-title":"A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients","volume":"18","author":"Hagen M","year":"2003","unstructured":"Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant. 2003, 18:2154-9. 10.1093\/ndt\/gfg338","journal-title":"Nephrol Dial Transplant"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv368","article-title":"Clinical evolution of post-transplant diabetes mellitus","volume":"31","author":"Porrini EL","year":"2016","unstructured":"Porrini EL, D\u00edaz JM, Moreso F, et al.. Clinical evolution of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2016, 31:495-505. 10.1093\/ndt\/gfv368","journal-title":"Nephrol Dial Transplant"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske BL","year":"2003","unstructured":"Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003, 3:178-85. 10.1034\/j.1600-6143.2003.00010.x","journal-title":"Am J Transplant"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00790-5","article-title":"Post-transplantation diabetes mellitus","volume":"11","author":"Ahmed SH","year":"2020","unstructured":"Ahmed SH, Biddle K, Augustine T, Azmi S. Post-transplantation diabetes mellitus. Diabetes Ther. 2020, 11:779-801. 10.1007\/s13300-020-00790-5","journal-title":"Diabetes Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad258","article-title":"International consensus on post-transplantation diabetes mellitus","volume":"39","author":"Sharif A","year":"2024","unstructured":"Sharif A, Chakkera H, de Vries AP, et al.. International consensus on post-transplantation diabetes mellitus. Nephrol Dial Transplant. 2024, 39:531-49. 10.1093\/ndt\/gfad258","journal-title":"Nephrol Dial Transplant"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.395449","article-title":"Prevalence and risk factors of new-onset diabetes after transplant in East Africans","volume":"34","author":"Nasir SO","year":"2023","unstructured":"Nasir SO, McCarthy H, Mohamed Ahmed IA. Prevalence and risk factors of new-onset diabetes after transplant in East Africans. Saudi J Kidney Dis Transpl. 2023, 34:331-6. 10.4103\/1319-2442.395449","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051174","article-title":"Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-years follow-up","volume":"12","author":"Tsai TY","year":"2022","unstructured":"Tsai TY, Chen CH, Wu MJ, Tsai SF. Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-years follow-up. Diagnostics (Basel). 2022, 12:1174. 10.3390\/diagnostics12051174","journal-title":"Diagnostics (Basel)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.07.011","article-title":"Diabetes mellitus and renal transplantation in adults: is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation?","volume":"46","author":"Suarez O","year":"2014","unstructured":"Suarez O, Pardo M, Gonzalez S, et al.. Diabetes mellitus and renal transplantation in adults: is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation?. Transplant Proc. 2014, 46:3015-20. 10.1016\/j.transproceed.2014.07.011","journal-title":"Transplant Proc"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02253-w","article-title":"Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis","volume":"61","author":"Du Q","year":"2024","unstructured":"Du Q, Li T, Yi X, Song S, Kang J, Jiang Y. Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. Acta Diabetol. 2024, 61:809-29. 10.1007\/s00592-024-02253-w","journal-title":"Acta Diabetol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073422","article-title":"Diabetes and cardiovascular risk in renal transplant patients","volume":"22","author":"Rysz J","year":"2021","unstructured":"Rysz J, Franczyk B, Radek M, Cia\u0142kowska-Rysz A, Gluba-Brz\u00f3zka A. Diabetes and cardiovascular risk in renal transplant patients. Int J Mol Sci. 2021, 22:3422. 10.3390\/ijms22073422","journal-title":"Int J Mol Sci"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13121706","article-title":"Adverse drug events after kidney transplantation","volume":"13","author":"Rostaing L","year":"2023","unstructured":"Rostaing L, Jouve T, Terrec F, Malvezzi P, Noble J. Adverse drug events after kidney transplantation. J Pers Med. 2023, 13:1706. 10.3390\/jpm13121706","journal-title":"J Pers Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57030250","article-title":"New-onset diabetes after kidney transplantation","volume":"57","author":"Ponticelli C","year":"2021","unstructured":"Ponticelli C, Favi E, Ferraresso M. New-onset diabetes after kidney transplantation. Medicina (Kaunas). 2021, 57:250. 10.3390\/medicina57030250","journal-title":"Medicina (Kaunas)"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1177\/15269248211002796","article-title":"Vitamin D levels and the risk of posttransplant diabetes mellitus after kidney transplantation","volume":"31","author":"Quach K","year":"2021","unstructured":"Quach K, Abdelmasih M, Chen PX, et al.. Vitamin D levels and the risk of posttransplant diabetes mellitus after kidney transplantation. Prog Transplant. 2021, 31:133-41. 10.1177\/15269248211002796","journal-title":"Prog Transplant"},{"key":"ref61","article-title":"Risk factors of new-onset diabetes after renal transplantation and prognostic analysis","volume":"29","author":"Wang Q","year":"2023","unstructured":"Wang Q, Wu J, Wang X, Huang Y, Li G, Ou T. Risk factors of new-onset diabetes after renal transplantation and prognostic analysis. Altern Ther Health Med. 2023, 29:230-5.","journal-title":"Altern Ther Health Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0828","article-title":"Tacrolimus-induced BMP\/SMAD signaling associates with metabolic stress-activated FOXO1 to trigger \u03b2-cell failure","volume":"69","author":"Tri\u00f1anes J","year":"2020","unstructured":"Tri\u00f1anes J, Ten Dijke P, Groen N, et al.. Tacrolimus-induced BMP\/SMAD signaling associates with metabolic stress-activated FOXO1 to trigger \u03b2-cell failure. Diabetes. 2020, 69:193-204. 10.2337\/db19-0828","journal-title":"Diabetes"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000069952.49242.3E","article-title":"New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003","volume":"75","author":"Davidson J","year":"2003","unstructured":"Davidson J, Wilkinson A, Dantal J, et al.. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003, 75:SS3-24. 10.1097\/01.TP.0000069952.49242.3E","journal-title":"Transplantation"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8431","article-title":"The effect of anemia and the goal of optimal HbA1c control in diabetes and non-diabetes","volume":"12","author":"Katwal PC","year":"2020","unstructured":"Katwal PC, Jirjees S, Htun ZM, Aldawudi I, Khan S. The effect of anemia and the goal of optimal HbA1c control in diabetes and non-diabetes. Cureus. 2020, 12:e8431. 10.7759\/cureus.8431","journal-title":"Cureus"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12042","article-title":"Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation","volume":"26","author":"Shabir S","year":"2013","unstructured":"Shabir S, Jham S, Harper L, Ball S, Borrows R, Sharif A. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation. Transpl Int. 2013, 26:315-21. 10.1111\/tri.12042","journal-title":"Transpl Int"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15650","article-title":"Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy","volume":"20","author":"Kassam AF","year":"2020","unstructured":"Kassam AF, Mirza A, Kim Y, et al.. Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. Am J Transplant. 2020, 20:422-9. 10.1111\/ajt.15650","journal-title":"Am J Transplant"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010116","article-title":"Prevention of post-transplant diabetes mellitus: towards a personalized approach","volume":"12","author":"Ducloux D","year":"2022","unstructured":"Ducloux D, Courivaud C. Prevention of post-transplant diabetes mellitus: towards a personalized approach. J Pers Med. 2022, 12:116. 10.3390\/jpm12010116","journal-title":"J Pers Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3390\/ph17080987","article-title":"Managing post-transplant diabetes mellitus after kidney transplantation: challenges and advances in treatment","volume":"17","author":"Rudzki G","year":"2024","unstructured":"Rudzki G, Knop-Chody\u0142a K, Piasecka Z, Kochanowska-Mazurek A, G\u0142az A, Weso\u0142ek-Bielaska E, Wo\u017aniak M. Managing post-transplant diabetes mellitus after kidney transplantation: challenges and advances in treatment. Pharmaceuticals (Basel). 2024, 17:987. 10.3390\/ph17080987","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v12.i7.184","article-title":"Metabolic and functional effects of exercise training in diabetic kidney transplant recipients","volume":"12","author":"Michou V","year":"2022","unstructured":"Michou V, Nikodimopoulou M, Deligiannis A, Kouidi E. Metabolic and functional effects of exercise training in diabetic kidney transplant recipients. World J Transplant. 2022, 12:184-94. 10.5500\/wjt.v12.i7.184","journal-title":"World J Transplant"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2019.02.004","article-title":"Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials","volume":"29","author":"Papamichou D","year":"2019","unstructured":"Papamichou D, Panagiotakos DB, Itsiopoulos C. Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials. Nutr Metab Cardiovasc Dis. 2019, 29:531-43. 10.1016\/j.numecd.2019.02.004","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2020.100071","article-title":"Efficacy and safety of insulin degludec in renal transplant recipients with pre-existing diabetes","volume":"31","author":"Sanyal D","year":"2021","unstructured":"Sanyal D, Chaudhuri SR, Majumder A. Efficacy and safety of insulin degludec in renal transplant recipients with pre-existing diabetes. Endocr Metab Sci. 2021, 31:100071. 10.1016\/j.endmts.2020.100071","journal-title":"Endocr Metab Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1321-2","article-title":"Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation","volume":"20","author":"Alnasrallah B","year":"2019","unstructured":"Alnasrallah B, Goh TL, Chan LW, Manley P, Pilmore H. Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation. BMC Nephrol. 2019, 20:147. 10.1186\/s12882-019-1321-2","journal-title":"BMC Nephrol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13302","article-title":"Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: a retrospective analysis of integrated registry and pharmacy claims data","volume":"32","author":"Vest LS","year":"2018","unstructured":"Vest LS, Koraishy FM, Zhang Z, et al.. Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: a retrospective analysis of integrated registry and pharmacy claims data. Clin Transplant. 2018, 32:e13302. 10.1111\/ctr.13302","journal-title":"Clin Transplant"},{"key":"ref74","article-title":"Effects of pioglitazone on blood glucose and inflammatory markers of diabetic kidney transplant patients: a randomized controlled trial","volume":"8","author":"Kharazmkia A","year":"2014","unstructured":"Kharazmkia A, Ahmadpoor P, Ziaei S, et al.. Effects of pioglitazone on blood glucose and inflammatory markers of diabetic kidney transplant patients: a randomized controlled trial. Iran J Kidney Dis. 2014, 8:408-16.","journal-title":"Iran J Kidney Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.12860\/jnp.2015.10","article-title":"Effect of pioglitazone therapy on high sensitive C-reactive protein and lipid profile in diabetic patients with renal transplantation; a randomize clinical trial","volume":"4","author":"Arashnia R","year":"2015","unstructured":"Arashnia R, Roohi-Gilani K, Karimi-Sari H, Nikjoo N, Bahramifar A. Effect of pioglitazone therapy on high sensitive C-reactive protein and lipid profile in diabetic patients with renal transplantation; a randomize clinical trial. J Nephropathol. 2015, 4:48-53. 10.12860\/jnp.2015.10","journal-title":"J Nephropathol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182347ea4","article-title":"Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation","volume":"92","author":"Lane JT","year":"2011","unstructured":"Lane JT, Odegaard DE, Haire CE, Collier DS, Wrenshall LE, Stevens RB. Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. Transplantation. 2011, 92:e56-7. 10.1097\/TP.0b013e3182347ea4","journal-title":"Transplantation"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.119572","article-title":"A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting","volume":"17","author":"Sanyal D","year":"2013","unstructured":"Sanyal D, Gupta S, Das P. A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting. Indian J Endocrinol Metab. 2013, 17:S203-5. 10.4103\/2230-8210.119572","journal-title":"Indian J Endocrinol Metab"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2013.0018","article-title":"Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant","volume":"11","author":"Soliman AR","year":"2013","unstructured":"Soliman AR, Fathy A, Khashab S, Shaheen N, Soliman MA. Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant. Exp Clin Transplant. 2013, 11:494-8. 10.6002\/ect.2013.0018","journal-title":"Exp Clin Transplant"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/617638","article-title":"Efficacy and safety of sitagliptin for the treatment of new-onset diabetes after renal transplantation","volume":"2014","author":"Boerner BP","year":"2014","unstructured":"Boerner BP, Miles CD, Shivaswamy V. Efficacy and safety of sitagliptin for the treatment of new-onset diabetes after renal transplantation. Int J Endocrinol. 2014, 2014:617638. 10.1155\/2014\/617638","journal-title":"Int J Endocrinol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000971","article-title":"The use of GLP1R agonists for the treatment of type 2 diabetes in kidney transplant recipients","volume":"6","author":"Kukla A","year":"2020","unstructured":"Kukla A, Hill J, Merzkani M, et al.. The use of GLP1R agonists for the treatment of type 2 diabetes in kidney transplant recipients. Transplant Direct. 2020, 6:e524. 10.1097\/TXD.0000000000000971","journal-title":"Transplant Direct"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus","volume":"42","author":"Halden TA","year":"2019","unstructured":"Halden TA, Kvitne KE, Midtvedt K, et al.. Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus. Diabetes Care. 2019, 42:1067-74. 10.2337\/dc19-0093","journal-title":"Diabetes Care"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2021.03.001","article-title":"Novel glucose-lowering therapies in the setting of solid organ transplantation","volume":"28","author":"Nissaisorakarn P","year":"2021","unstructured":"Nissaisorakarn P, Pavlakis M, Aala A. Novel glucose-lowering therapies in the setting of solid organ transplantation. Adv Chronic Kidney Dis. 2021, 28:361-70. 10.1053\/j.ackd.2021.03.001","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","unstructured":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes. collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022, 400:1788-801. 10.1016\/S0140-6736(22)02074-8","journal-title":"Lancet"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2021.101.3.187","article-title":"Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve \u03b2 cell function","volume":"101","author":"Jang HW","year":"2021","unstructured":"Jang HW, Jung CH, Ko Y, et al.. Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve \u03b2 cell function. Ann Surg Treat Res. 2021, 101:187-96. 10.4174\/astr.2021.101.3.187","journal-title":"Ann Surg Treat Res"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009966.pub3","article-title":"Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients","volume":"8","author":"Lo C","year":"2020","unstructured":"Lo C, Toyama T, Oshima M, Jun M, Chin KL, Hawley CM, Zoungas S. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. Cochrane Database Syst Rev. 2020, 8:CD009966. 10.1002\/14651858.CD009966.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.07.009","article-title":"Randomized controlled trial assessing the impact of tacrolimus versus cyclosporine on the incidence of posttransplant diabetes mellitus","volume":"3","author":"Torres A","year":"2018","unstructured":"Torres A, Hern\u00e1ndez D, Moreso F, et al.. Randomized controlled trial assessing the impact of tacrolimus versus cyclosporine on the incidence of posttransplant diabetes mellitus. Kidney Int Rep. 2018, 3:1304-15. 10.1016\/j.ekir.2018.07.009","journal-title":"Kidney Int Rep"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14665","article-title":"Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation","volume":"18","author":"Wissing KM","year":"2018","unstructured":"Wissing KM, Abramowicz D, Weekers L, et al.. Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation. Am J Transplant. 2018, 18:1726-34. 10.1111\/ajt.14665","journal-title":"Am J Transplant"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.07.016","article-title":"Glucose metabolism after kidney transplantation: insulin release and sensitivity with tacrolimus- versus belatacept-based immunosuppression","volume":"77","author":"M\u00fcller MM","year":"2021","unstructured":"M\u00fcller MM, Schwaiger E, Kurnikowski A, et al.. Glucose metabolism after kidney transplantation: insulin release and sensitivity with tacrolimus- versus belatacept-based immunosuppression. Am J Kidney Dis. 2021, 77:462-4. 10.1053\/j.ajkd.2020.07.016","journal-title":"Am J Kidney Dis"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1851596","article-title":"pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression","volume":"14","author":"Chevallier E","year":"2021","unstructured":"Chevallier E, Jouve T, Rostaing L, Malvezzi P, Noble J. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression. Expert Rev Clin Pharmacol. 2021, 14:55-66. 10.1080\/17512433.2021.1851596","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181e58912","article-title":"A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation","volume":"90","author":"Pascual J","year":"2010","unstructured":"Pascual J, Galeano C, Royuela A, Zamora J. A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation. Transplantation. 2010, 90:343-9. 10.1097\/TP.0b013e3181e58912","journal-title":"Transplantation"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13783","article-title":"Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking M","year":"2021","unstructured":"Hecking M, Sharif A, Eller K, Jenssen T. Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics. Transpl Int. 2021, 34:27-48. 10.1111\/tri.13783","journal-title":"Transpl Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341197-exploring-the-impact-of-diabetes-on-kidney-transplant-patient-outcomes-and-management-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:40:44Z","timestamp":1742409644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341197-exploring-the-impact-of-diabetes-on-kidney-transplant-patient-outcomes-and-management-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":91,"URL":"https:\/\/doi.org\/10.7759\/cureus.80843","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}